google_counter
Chemotherapy in multiple myeloma (316559) | Medipol Mega University Hospital Istanbul - BookingHealth
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>clinical history taking<\/li>\n\t<li>review of medical records<\/li>\n\t<li>physical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>urinalysis for&nbsp;Bence-Jones protein<\/li>\n\t\t<li>differential blood count<\/li>\n\t\t<li>protein electrophoresis<\/li>\n\t\t<li>immunofixation<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>inflammation indicators (CRP, ESR)<\/li>\n\t\t<li>indicators of blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>individual&nbsp;plan of the chemotherapy<\/li>\n\t<li>the cost of medicines and symptomatic treatment:\n\t<ul>\n\t\t<li>lenalidomide<\/li>\n\t\t<li>bortezomib<\/li>\n\t\t<li>thalidomide<\/li>\n\t\t<li>bisphosphonates<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>nursing services<\/li>\n\t<li>control examinations<\/li>\n\t<li>consultations of related specialists<\/li>\n\t<li>recommendations for further therapy<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).<\/p>\n\n<p style=\"text-align:justify\"><strong>Chemotherapy&nbsp;<\/strong>is carried out as the day hospital procedure, without mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the course of chemotherapy<\/strong>, you will stay under medical supervision in the ward for a few more hours. If your general condition is good, your doctor will allow you to leave the hospital. You will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li style=\"text-align: justify;\">Bone marrow biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the clinic<\/li>\n\t<li>clinical history taking<\/li>\n\t<li>review of medical records<\/li>\n\t<li>physical examination<\/li>\n\t<li>laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>urinalysis for&nbsp;Bence-Jones protein<\/li>\n\t\t<li>differential blood count<\/li>\n\t\t<li>protein electrophoresis<\/li>\n\t\t<li>immunofixation<\/li>\n\t\t<li>TSH-basal, fT3, fT4<\/li>\n\t\t<li>inflammation indicators (CRP, ESR)<\/li>\n\t\t<li>indicators of blood coagulation<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>individual&nbsp;plan of the chemotherapy<\/li>\n\t<li>the cost of medicines and symptomatic treatment:\n\t<ul>\n\t\t<li>lenalidomide<\/li>\n\t\t<li>bortezomib<\/li>\n\t\t<li>thalidomide<\/li>\n\t\t<li>bisphosphonates<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>nursing services<\/li>\n\t<li>control examinations<\/li>\n\t<li>consultations of related specialists<\/li>\n\t<li>recommendations for further therapy<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).<\/p>\n\n<p style=\"text-align:justify\"><strong>Chemotherapy&nbsp;<\/strong>is carried out as the day hospital procedure, without mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the course of chemotherapy<\/strong>, you will stay under medical supervision in the ward for a few more hours. If your general condition is good, your doctor will allow you to leave the hospital. You will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.<\/p>\n<\/div>","is_ambulant":"1","bh_fee":"0","only_for_children":"0","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"2","clinic_icon":"5ffffc5395c03.jpg","city":"Istanbul","clinic_site":"https:\/\/www.medipol.com.tr\/en\/","department_recommend":"0","country":"Turkey","country_id":"10","clinic_name":"Medipol Mega University Hospital Istanbul","cinic_name":"Medipol Mega University Hospital Istanbul","department_id":"1833","duration":"5","direction":"Hematology","min_duration":0,"clinic_id":"1377","paketPrice":"0.00","paket":"<ul>\n <li> Interpreter up to 8 hours<\/li>\n <li>Translation of up to 5 pages<\/li>\n <li>Visa support<\/li>\n\n<\/ul>","title":"Chemotherapy in multiple myeloma","price":{"val":7952.15,"type":"val"},"price_surcharge":8492.15,"price_surcharge_clear":"540.00","extra_service_clinic":[],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"31","distance":"33","airport_title":"Istanbul"},{"id":"32","distance":"165","airport_title":"Bursa"},{"id":"33","distance":"480","airport_title":"Ankara"}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Chemotherapy in multiple myeloma in Medipol Mega University Hospital Istanbul

Medipol Mega University Hospital Istanbul

Istanbul, Turkey
Program id # 316559
Doctor photo
Prof. Dr. med. Fatma Deniz Sargin
Department of Adult and Pediatric Oncology, Hematology, Radiation Therapy and Bone Marrow Transplant
Specialized in: adult and pediatric oncology, hematology, radiation therapy, bone marrow transplant

The program includes:

  • Initial presentation in the clinic
  • clinical history taking
  • review of medical records
  • physical examination
  • laboratory tests:
    • complete blood count
    • biochemical analysis of blood
    • urinalysis for Bence-Jones protein
    • differential blood count
    • protein electrophoresis
    • immunofixation
    • TSH-basal, fT3, fT4
    • inflammation indicators (CRP, ESR)
    • indicators of blood coagulation
  • individual plan of the chemotherapy
  • the cost of medicines and symptomatic treatment:
    • lenalidomide
    • bortezomib
    • thalidomide
    • bisphosphonates
  • nursing services
  • control examinations
  • consultations of related specialists
  • recommendations for further therapy

How program is carried out

During the first visit, the doctor will conduct a clinical examination and go through the results of previous laboratory tests and instrumental examinations. After that, you will undergo an additional examination, including laboratory assessment of liver and kidney function, ultrasound scan. Based on the received results, the doctor will elaborate the chemotherapy regimen. If necessary, related medical specialists will be involved in the elaboration of a treatment regimen (tumor board).

Chemotherapy is carried out as the day hospital procedure, without mandatory admission to the hospital. After the placement of a venous catheter, you will stay in a comfortable ward. An infusion system will be connected to the catheter, through which the required drug or a drug combination will be administered. All drugs are administered by intravenous drip, slowly, so the total duration of the infusion can be up to several hours. All this time, doctors and nurses will monitor your health condition closely.

After the course of chemotherapy, you will stay under medical supervision in the ward for a few more hours. If your general condition is good, your doctor will allow you to leave the hospital. You will receive the medical report with detailed recommendations regarding further treatment. In the future, you will be able to have a distant consultation with your attending physician and schedule the next course of chemotherapy, if necessary.

Required documents

  • Medical records
  • MRI/CT scan (not older than 3 months)
  • Bone marrow biopsy results (if available)

Service

Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Hospital directly:
Saving:
Guarantee BookingHealth Price from:

About the department

The Department of Adult and Pediatric Oncology, Hematology, Radiation Therapy and Bone Marrow Transplant at the Medipol Mega University Hospital Istanbul offers diagnostics and comprehensive treatment of the full range of oncological diseases, as well as benign and malignant blood diseases in children and adults. The department is an interdisciplinary center, which treats patients with all types of tumors. The department specializes in the treatment of lung, breast, prostate, colorectal, esophageal and stomach cancers, melanoma, sarcomas, head and neck, brain and neuroendocrine tumors. The Chief Physician of the department is Prof. Dr. med. Fatma Deniz Sargin.

The department ranks among the leading Cancer Centers for adults and children in Turkey. All the very latest treatment methods are available for cancer treatment, including radiation therapy, chemo-, hormone and targeted therapy. To treat neuroblastomas and other neuroendocrine tumors, the department in cooperation with the Department of Nuclear Medicine successfully applies radioactive iodine therapy (MIBG therapy). Thanks to the interdisciplinary approach, long experience of the doctors and the use of advanced methods (intraoperative radiation, targeted therapy, etc.), the department demonstrates very high treatment efficiency rates.

The service range in hematology includes all benign (for example, iron deficiency anemia, vitamin B12 deficient and folic acid deficiency anemia) and malignant blood diseases (for example, acute and chronic leukemia, multiple myeloma, lymphomas, etc). The diagnostics of blood diseases is carried out with the use of the very latest methods. These include cytogenetic examination of bone marrow and blood cells, various types of lymph node and organ biopsy, etc.

In addition, the department is a recognized Bone Marrow Transplant Center. The transplantation can be performed for such diseases as multiple myeloma, lymphoma (lymph node cancer), acute and chronic leukemia (blood cancer), etc. The department incorporates the specialized Pediatric Center for Bone Marrow Transplant. The indications for the treatment in the Pediatric Center are diseases, such as leukemia, lymphoma and other hard-to-cure cancer types, congenital or acquired blood diseases (for example, Mediterranean anemia), congenital or acquired bone marrow diseases (for example, aplastic anemia), etc.

The department’s range includes the diagnostics and treatment of the following diseases:

  • Diagnostics and treatment of cancer
    • Lung cancer
    • Breast cancer in women
    • Prostate cancer
    • Colorectal cancer
    • Stomach cancer
    • Esophageal cancer
    • Melanomas and other skin cancers
    • Sarcomas
    • Head and neck tumors
    • Brain cancer
    • Neuroendocrine tumors
  • Diagnostics and treatment of diseases of the hematopoietic system
    • Acute leukemia
    • Chronic leukemia
    • Multiple myeloma
    • Waldenstrom's macroglobulinemia 
    • Light chain deposition disease
    • Hodgkin’s lymphoma
    • Non-Hodgkin’s lymphoma
  • Diagnostics and treatment of cancers and hematopoietic diseases in children
    • Acute lymphoblastic leukemia in children
    • Acute myeloblastic leukemia in children
    • Non-Hodgkin's lymphomas in children
    • Hodgkin's lymphomas in children
    • Brain and spinal cord tumors
    • Neuroblastoma
    • Wilms’ tumor and other kidney tumors in children
    • Soft tissue sarcomas
    • Ewing's sarcoma
    • Osteosarcoma and malignant fibrous histiocytoma
    • Rhabdomyosarcoma
    • Liver cancer
    • Rare cancers in children
  • Bone marrow transplant
    • Multiple myeloma
    • Lymphoma 
    • Acute leukemia
    • Chronic leukemia
    • Bone marrow diseases (aplastic anemia)
    • Myelodysplastic syndrome (MDS)
  • Other diseases in children and adults

Curriculum vitae

Education and Professional Career

  • 1967 - 1978 Study of Internal Medicine, Faculty of Medicine, Istanbul University.
  • 1979 - 1983 Internship, Department of Internal Medicine and Hematology, Faculty of Medicine, Istanbul University.
  • 1988 Professorship.
  • 1988 Professor, Doctor of Medicine, Department of Internal Medicine and Hematology, Faculty of Medicine, Istanbul University.
  • 2010 Specialization in Hematology.

Photo of the doctor: (c) Medipol Mega University Hospital Istanbul 


About hospital

Accommodation in hospital

Hospital accommodation

The patients and their families can stay at the Medipol Guest House, which is a 1-minute walk from the Medipol Mega University Hospital Istanbul.